Peptide Dosage Charts, Trends & Reconstitution Data | World Peptide Association

Peptide Dosage Charts, Trends & Reconstitution Data | World Peptide Association

Peptide Dosage

Explore peptide dosage patterns from 125,304+ anonymized calculator inputs, including common dose selections, vial sizes, BAC water amounts, and compound-specific reconstitution trends. For the full methodology behind this data family, see WPA's cross-compound reconstitution study.

Peptide Researchers (24hr)

1,067 active

Lifetime Vendor Clicks

26,086+ trusted vendor checks

Fastest Growing Peptide

DSIP ▲ 863% (30d)

WPA TRUTH

Why Peptide Dosage Data Needed a New Source of Ground Truth

Most peptide dosage information online comes from scattered sources: Reddit threads, bodybuilding forums, influencer videos, and one-off personal reports. Some of that information can be useful, but it has a major limitation. It's one person's protocol — still just one story (sample size = 1). It does not show the market's truth for a specific compound.

Formal research has a different problem. It can be careful and well-controlled, but it usually follows the money. The focus tends to land on patented drugs, approved products, or questions that lead to a clear financial return. That means many compounds, dose ranges, reconstitution methods, and real-world research patterns are never studied in a serious way.

So the gap stays open.

People want to know what is actually happening, but the answers are spread across forums, vendors, private groups, and personal experience. There has not been one live source showing what researchers are really calculating across the peptide marketplace.

That is why WPA exists.

The World Peptide Association built a free peptide reconstitution calculator now used across 182 compounds. Each calculation creates a structured, anonymized data point: compound selected, vial size, BAC water volume, desired dose, and — when users calculate vial duration — intended dosing frequency.

That makes WPA more than a calculator. It is becoming the live data layer for peptide research — a real-time map of what researchers are calculating before they prepare a vial.

The charts below are built from 125,304+ anonymized calculator inputs across the WPA ecosystem. They show which compounds are gaining attention, which dose ranges are most common, which vial sizes dominate, which BAC water volumes researchers prefer, and how dosing frequency changes by compound.

This is not medical advice, a dosing recommendation, or proof of use. It is market intelligence for peptide research — showing what researchers are calculating at scale, not what anyone should take, inject, prescribe, or consume.

Peptide Dosage Trends by Research Category

Research peptide categories ranked by lifetime calculator volume, with 30-day growth rate — see which categories are most active and which are growing fastest.

Weight Loss 68.4k ▲55% Anti-Aging 38.7k ▲98% Performance 30.3k ▲69% Skin 25.9k ▲97% Recovery 25.8k ▲76% Muscle 15.3k ▲65% Memory 13.2k ▲115% Testosterone 4k ▲54% Other 41 ▲46% Global Peptide Calculation Analytics Peptide Dosage Activity by Compound

Ranked by real calculator inputs from WPA researchers, this chart shows the most actively used peptide compounds in the marketplace. Use the filters to explore by research category or time period and see which compounds are generating the most interest right now.

Show: Top 10 Period: Lifetime Filter: All Metabolic Recovery Longevity 125,304 calculations WorldPeptideAssociation.com Retatrutide Tirzepatide CJC-1295 No DAC/Ipamorelin NAD+ MOTS-c GHK-Cu Glutathione Semaglutide KLOW Tesamorelin 0 10000 20000 30000 40000 Total Calculations

What This Chart Shows

This chart ranks peptides by total reconstitution calculations run across anonymized WPA calculator activity. Higher bars indicate compounds with more logged calculation volume.

Current Leader

Retatrutide currently ranks highest in the dataset with 39,212 calculations. This suggests it generates the most calculator activity among the compounds shown.

Data Source

All values come from anonymized WPA reconstitution calculator inputs. Figures reflect aggregate calculator activity rather than surveys, assumptions, or personally identifiable user data.

Compare Vendors for Retatrutide

See current vendor options, pricing, and sourcing data for Retatrutide based on the vendor page. Current listings start at $36.25 per vial across 14 vendors.

Compare Vendors

WPA MARKET SIGNAL

Peptide Dosage Trends Show Where Research Demand Is Concentrated — and Where It Is Moving Next

Most peptide trend data only shows search interest. WPA shows something more useful: what researchers are actually calculating.

The category card above group compounds into major research areas like weight loss, performance, anti-aging, recovery, skin, muscle, memory, testosterone, and other peptides. Each category is ranked by total calculator activity across the compounds inside it. That makes the chart a live view of which research areas are getting the most attention across the peptide marketplace.

Right now, Weight Loss leads all categories with 68,428+ peptide calculator inputs. But total size is only one signal. Growth matters too. The fastest-rising category over the last 30 days is Memory Peptides, up 115%.

The compound chart above shows the same marketplace from another angle. Instead of grouping peptides by category, it ranks individual compounds across the full WPA dataset of 182 compounds. This shows which peptides are creating the most real calculator activity overall.

The top of the chart is currently led by weight loss, muscle peptides, and anti-aging peptides compounds like Retatrutide, Tirzepatide, and CJC-1295 No DAC/Ipamorelin Blend, with NAD+ also holding a major position in total demand. But the lower half of the top ten changes more often. That movement is the signal. It shows which compounds are gaining attention, which ones are cooling off, and where researcher interest may be shifting before it becomes obvious elsewhere.

This is why WPA tracks both category-level trends and compound-level activity. Categories show the broad direction of the market. Individual compounds show the heartbeat underneath it.

This is not medical advice, a dosing recommendation, or proof of use. It is market intelligence for peptide research — showing what researchers are calculating at scale, not what anyone should take, inject, prescribe, or consume.

Peptide Dosing Trends Over Time

Select any combination of peptides to see how researcher interest in each compound has shifted over time. Spot which are gaining momentum, which are declining, and how they stack up against each other — use rolling averages to filter out daily noise and surface sustained directional trends.

Compare: + Add compound Smoothing: Daily 7d avg 30d avg 90d avg Loading trend data…

Axes

X-axis shows time across the full available data history. Y-axis shows calculation volume, either as raw daily counts or a rolling average based on the smoothing option selected.

Rolling Averages

Selecting 7-day avg means each point shows the average of the prior 7 days of calculations. Longer windows like 30d and 90d smooth short-term spikes and make broader trends easier to see. Daily shows raw counts with no smoothing.

Early Data Note

Rolling averages near the start of the timeline may appear lower than later values. That is expected because there are fewer prior days available in the trailing average window.

Data Source

All values come from anonymized WPA peptide calculator sessions. Each point reflects the calculation volume for that compound at that moment in the selected trend view.

WPA VELOCITY WATCH

Peptide Research Activity Trajectories Tell You Which Compounds Are Gaining Ground — and Which Are Giving It Back

Most rankings tell you where a compound stands at a single moment in time. This chart tells you something more valuable: whether that position is strengthening or eroding. The slope of each line across a 90-day rolling window is how sustained conviction in a compound expresses itself at scale — not as a spike, but as a directional shift in how many researchers are actively running calculations. Flattening lines and crossing lines are the signal. Everything else is noise.

What WPA is observing right now across the GLP-1 class is a structural rotation in research attention. Tirzepatide held the top position in 90-day calculator volume for an extended stretch. But the trend line has been gradually declining over the last several months — slowly, steadily, and consistently. Retatrutide, by contrast, sat flat across that same window. Then, in the weeks leading into Q1 2025, Retatrutide's 90-day rolling average began climbing. At some point during that period, the two lines crossed. Retatrutide now carries the higher sustained calculator volume of the two. A crossover on a 90-day average does not happen on noise. It reflects a real shift in where research attention within the GLP-1 category is being directed — and the WPA data captured it in real time.

A parallel story is playing out one tier below. For approximately two months, Semaglutide sat as the fourth most active compound by calculation volume, trailing BPC-157 consistently. Beginning in mid-to-late March 2025, Semaglutide's 90-day line began steepening. BPC-157, meanwhile, had flattened out — and over the same window, showed a slight downward drift. Semaglutide crossed above BPC-157 and has held that position since. The exact driver behind the shift — whether renewed clinical trial coverage, vendor availability changes, or broader GLP-1 attention — sits outside the data. But the direction of researcher behavior is unambiguous.

These are exactly the kinds of movements the WPA time-series chart was built to surface. Rolling averages exist to filter out short-term spikes and isolate sustained trends. When you set the view to 90-day and watch crossovers appear in real time, you are watching the peptide marketplace's collective research behavior — not just what is popular today, but what is gaining ground and what is quietly losing it. WPA is the only source of this kind of granular, compound-level, real-time research activity data built directly from peptide calculation behavior at scale. No other platform is tracking this.

Trend observations reflect historical WPA calculator input patterns only and are not predictive, medical, or investment advice. Compound names are used for research identification purposes only.

Peptide Research Demand: Vendor Clicks vs. Calculator Activity

Compare supplier click activity with calculator volume to see which peptides show stronger research demand, sourcing intent, or both.

Show: Top 5 Period: All Time X = Calcs Y = Clicks Size = Growth Loading data...

WPA DEMAND INTELLIGENCE

When Research Activity and Sourcing Intent Diverge, That Gap Is the Most Interesting Signal on the Chart

Most compound popularity rankings flatten the question into a single dimension: which peptide has the most activity. This chart does something more revealing. It plots two completely independent signals against each other — how many researchers are actively running calculations on a compound, and how many are clicking through to find a vendor who carries it. When those two signals align, a compound is both studied and sought. When they diverge, the gap itself becomes the most informative data point on the chart.

The relationship between Semaglutide and BPC-157 illustrates this clearly. Semaglutide now logs more total calculator activity than BPC-157 — its horizontal position on the chart reflects that. But BPC-157 consistently draws more vendor click-throughs. Measured against its calculation volume, BPC-157 generates proportionally stronger sourcing intent per researcher interaction than Semaglutide does. That is not a ranking quirk. It suggests that BPC-157 researchers are further along in their decision process — more of them are ready to source, not just calculate.

Retatrutide presents the inverse case. Its bubble currently shows one of the highest growth rates among the top five compounds — an expanding purple bubble reflecting the same momentum the trend chart captures. But its vendor click count sits comparatively low relative to that growth. That kind of pattern — accelerating research activity without matching sourcing intent — frequently precedes a sourcing inflection. Interest is building. Commercial behavior has not caught up yet.

GHK-Cu occupies a different position entirely. Its calculator activity runs at roughly half the volume of BPC-157, but the vendor click gap is even wider in proportion — placing it distinctly in the lower-right quadrant where research interest is real but commercial traction is limited. Whether that reflects supply availability, compound familiarity, or researcher behavior patterns is outside the data. But the WPA chart is the only place where this kind of compound-level, dual-signal comparison exists — research activity and sourcing intent measured together, in the same frame, updated in real time.

Vendor click data reflects anonymized click-through events recorded within the WPA platform and does not represent completed purchases or verified sourcing intent. All data is for research intelligence purposes only.

Most Common Peptide Vial Sizes

See which vial sizes are most commonly entered into the WPA reconstitution calculator across peptide research compounds.

Loading data... Most Common Peptide BAC Water Volumes

See which peptide BAC water volumes are most commonly entered for reconstitution across anonymized WPA calculator sessions.

125,304 calculations Loading data...

WPA RECONSTITUTION INSIGHT

How Researchers Mix Their Peptides: Real-World Reconstitution Volumes Explained

The bar chart above shows that 2mL is the most-selected reconstitution volume at 42% of all logged calculations — but it is not a single dominant spike. 3mL sits right behind it at 32%, which means the top two volumes together account for roughly 74% of everything in the chart. 1mL follows as a meaningful third at 16%, and 1.5mL and below each capture only a few percent. The honest read of the chart is that researcher behavior clusters around two preferred volumes (2mL and 3mL), with a long tail of less-common choices.

Why do 2mL and 3mL together dominate the bar chart? The vial-sizes pie chart above is the explanation. 10mg vials account for roughly 31% of logged reconstitutions and 5mg vials another 14.7% — together those two formats represent about 45.7% of the 125,304+ calculations on this site, far more than any other vial-size combination. For a standard 5mg or 10mg lyophilized vial, both 2mL and 3mL of BAC water produce clean syringe-mark math: 2mL favors slightly more concentrated draws (often 0.1mL per dose), while 3mL stretches the same vial into a more dilute, finer-titration draw. Both are rational responses to the same vial sizes, which is why both bars are tall rather than just one.

1mL and 1.5mL together represent about 20% of calculations and reflect a different philosophy — concentrated reconstitution where each injection is a smaller physical volume. The tradeoff is that the math becomes less forgiving: small measurement errors have a bigger impact on the final dose when the concentration is high. This is a clear minority approach, but a meaningful one.

5mL is a clear outlier at only 2% of calculations. A standard lyophilized peptide vial is typically a 2mL or 3mL glass vial, which physically cannot accept 5mL of liquid — so researchers selecting 5mL are most likely working with larger-format compounds (such as glutathione or NAD+) that ship in vials purpose-built to hold that volume. The chart alone doesn’t prove which compounds drive this slice, but the size of the gap between 5mL and the next-nearest volume is consistent with a structurally distinct subset of the dataset.

The line chart on the right adds important depth. It tracks the percentage of researchers choosing more than 2mL across eight vial-size tiers, from ≤5mg up to 500mg+. The line rises from left to right, but not at a constant rate. At ≤5mg vials, only 27% of researchers use more than 2mL — meaning the great majority stay at 2mL or under. That tracks with the pie chart above: small-vial formats are exactly where 2mL math works cleanest.

The most notable jump in the line chart is between the 21–30mg tier (39%) and the 31–50mg tier (55%) — a 16-percentage-point leap. This is the crossover: below ~30mg, most researchers stay at 2mL or under; above ~30mg, most move higher. Vials larger than 30mg generally need more solvent to dissolve fully, and the resulting concentration math makes 3mL or more the cleaner choice. By the 500mg+ tier, that figure reaches 77%, a near-complete reversal of the behavior seen at the small-vial end.

Together, these charts show that reconstitution volume is tightly governed by vial size. The bar chart captures aggregate behavior — which is why 2mL and 3mL both lead, since 5mg and 10mg vials together drive close to half of all logged calculations on the site. The line chart peels back that aggregate to show the underlying logic: as vial size grows, BAC water volume grows with it. Researchers aren’t picking volumes at random — they’re responding to the vial format in front of them.

Fastest-Rising Peptides by Recent Calculator Activity

Compounds ranked by 30-day growth in dosage calculator activity versus the prior 30 days, with a minimum-activity threshold so the trends reflect real research demand instead of noise. Use it to spot accelerating peptide dosage trends and compare live vendor pricing alongside each mover. (Green = Growing; Red = Declining).

1 Retatrutide Trends View Dosing Data Smart Dosing $36.25 Compare 14 vendors 2 Tirzepatide Trends View Dosing Data Smart Dosing $25.00 Compare 14 vendors 3 CJC-1295 No DAC/Ipamorelin Blend Trends View Dosing Data Smart Dosing $28.50 Compare 14 vendors 4 NAD+ Trends View Dosing Data $37.61 Compare 15 vendors 5 MOTS-c Trends View Dosing Data Smart Dosing $24.50 Compare 13 vendors 6 GHK-Cu Trends View Dosing Data Smart Dosing $17.26 Compare 16 vendors 7 Glutathione Trends View Dosing Data $26.96 Compare 11 vendors 8 Semaglutide Trends View Dosing Data Smart Dosing $20.00 Compare 12 vendors 9 KLOW Blend Trends View Dosing Data $66.25 Compare 12 vendors 10 Tesamorelin Trends View Dosing Data $25.00 Compare 12 vendors Verified Supplier Directory Looking for Safe Sources?

Access the Verified Supplier Directory

Stop overpaying for untested vials. Compare live pricing, view third-party COAs, and unlock exclusive promo codes for the top 15+ trusted research suppliers.

COA Verified Promo Codes Included 15+ Trusted Suppliers Compare Verified Vendors & Prices

⭐ Trusted by 19,000+ Researchers•💰 Active Promo Codes Included

Frequently Asked Questions How accurate are these peptide dosage charts? What is the most popular research peptide right now? How do I calculate my own peptide reconstitution? Is this dosing data intended for medical advice?